Change the management of patients with heart failure: Rationale and design of the CHAMP-HF registry

American Heart Journal

Volumn 189, Issue , 2017, Pages 177-183

  DeVore, Adam D ^a,b   Thomas, Laine ^a   Albert, Nancy M ^c   Butler, Javed ^d   Hernandez, Adrian F ^a,b   Patterson, J Herbert ^e   Spertus, John A ^f   Williams, Fredonia B ^g   Turner, Stuart J ^h   Chan, Wing W ^h   Duffy, Carol I ^h   McCague, Kevin ^h   Mi, Xiaojuan ^a   Fonarow, Gregg C ⁱ  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d STONY BROOK UNIVERSITY   (United States)

^e University of North Carolina   (United States)

^f SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^g Mended Hearts   (United States)

^h NOVARTIS PHARMA AG   (Switzerland)

ⁱ UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIAC PATIENT; DISEASE REGISTRY; HEALTH CARE PERSONNEL; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; MANAGED CARE; MEDICATION COMPLIANCE; OUTPATIENT; PATIENT ASSESSMENT; PATIENT CARE; PATIENT-REPORTED OUTCOME; PRIORITY JOURNAL; STUDY DESIGN; TREATMENT OUTCOME; AMBULATORY CARE; CLINICAL TRIAL; DISEASE MANAGEMENT; FEMALE; MALE; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; PROSPECTIVE STUDY; REGISTER; UNITED STATES;

AMBULATORY CARE; DISEASE MANAGEMENT; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; UNITED STATES;

EID: 85019063158     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2017.04.010     Document Type: Article

References (24)

1. 1. Writing Group Members, Mozaffarian, D., Benjamin, E.J., et al. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation 133 (2016), e38–360.
2. 2. Writing Committee Members, Yancy, C.W., Jessup, M., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128 (2013), e240–e327.
3. 3. Cheng, R.K., Cox, M., Neely, M.L., et al. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. Am Heart J 168 (2014), 721–730.
4. 4. Heidenreich, P.A., Albert, N.M., Allen, L.A., et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 6 (2013), 606–619.
5. 5. Braunwald, E., Heart failure. JACC Heart Fail 1 (2013), 1–20.
6. 6. McMurray, J.J.V., Packer, M., Desai, A.S., et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371 (2014), 993–1004.
7. 7. Swedberg, K., Komajda, M., Bohm, M., et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376 (2010), 875–885.
8. 8. Institute of Medicine, Crossing the quality chasm: a new health system for the 21st century. The National Academies of Sciences, Engineering, and Medicine. web site https://www.nationalacademies.org/hmd/~/media/Files/Report%20Files/2001/Crossing-the-Quality-Chasm/Quality%20Chasm%202001%20%20report%20brief.pdf [Published March 2001. Accessed January 27, 2017].
9. 9. Fonarow, G.C., Yancy, C.W., Hernandez, A.F., et al. Potential impact of optimal implementation of evidence-based heart failure therapies on mortality. Am Heart J, 161, 2011 1024-1030.e3.
10. 10. Writing Committee Members, Yancy, C.W., Jessup, M., et al. 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation 134 (2016), e282–e293.
11. 11. Fonarow, G.C., Yancy, C.W., Heywood, J.T., Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry. Arch Intern Med 165 (2005), 1469–1477.
12. 12. Hernandez, A.F., Fonarow, G.C., Liang, L., et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA 298 (2007), 1525–1532.
13. 13. Fonarow, G.C., Yancy, C.W., Albert, N.M., et al. Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Circ Heart Fail 1 (2008), 98–106.
14. 14. Fonarow, G.C., Abraham, W.T., Albert, N.M., et al. Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF). Am J Cardiol 104 (2009), 107–115.
15. 15. Golwala, H., Pandey, A., Ju, C., et al. Temporal trends and factors associated with cardiac rehabilitation referral among patients hospitalized with heart failure: findings from Get With The Guidelines-Heart Failure Registry. J Am Coll Cardiol 66 (2015), 917–926.
16. 16. Pandey, A., Golwala, H., DeVore, A.D., et al. Trends in the use of guideline-directed therapies among dialysis patients hospitalized with systolic heart failure: findings from the American Heart Association Get With The Guidelines-Heart Failure Program. JACC Heart Fail 4 (2016), 649–661.
17. 17. Adams, K.F. Jr., Fonarow, G.C., Emerman, C.L., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100, 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149 (2005), 209–216.
18. 18. Fonarow, G.C., Abraham, W.T., Albert, N.M., et al. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. Am Heart J 148 (2004), 43–51.
19. 19. Ellrodt, A.G., Fonarow, G.C., Schwamm, L.H., et al. Synthesizing lessons learned from Get With The Guidelines: the value of disease-based registries in improving quality and outcomes. Circulation 128 (2013), 2447–2460.
20. 20. DeVore, A.D., Cox, M., Eapen, Z.J., et al. Temporal trends and variation in early scheduled follow-up after a hospitalization for heart failure: findings from Get With The Guidelines-Heart Failure. Circ Heart Fail, 9, 2016 e002344.
21. 21. Kociol, R.D., Peterson, E.D., Hammill, B.G., et al. National survey of hospital strategies to reduce heart failure readmissions: findings from the Get With the Guidelines-Heart Failure registry. Circ Heart Fail 5 (2012), 680–687.
22. 22. Fonarow, G.C., Yancy, C.W., Albert, N.M., et al. Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. Am Heart J 154 (2007), 12–38.
23. 23. Fonarow, G.C., Albert, N.M., Curtis, A.B., et al. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation 122 (2010), 585–596.
24. 24. Chan, P.S., Oetgen, W.J., Buchanan, D., et al. Cardiac performance measure compliance in outpatients: the American College of Cardiology and National Cardiovascular Data Registry's PINNACLE (Practice Innovation And Clinical Excellence) program. J Am Coll Cardiol 56 (2010), 8–14.